Elisabeth Kruse, PhD
McNeil AB
30
0
30
N/A
0
0
Research Impact
N/A
Research impact score
0
Total publications
0
Published trial results
0
Total citations
Drug Portfolio
+26 more interventions
Analytics
Trial Phases
Trial Status
Role Distribution
Activity Timeline
Clinical Trials (20)
Showing 10 of 20 trials
Research Network
Collaboration Network
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
Susan Hewlings
Radicle Science
Shared therapeutic areas:
Elliot Stein, Ph.D.
National Institute on Drug Abuse (NIDA)
Shared therapeutic areas:
Gisèle Pickering
University Hospital, Clermont-Ferrand
Shared therapeutic areas:
Paolo Bonato, PhD
Spaulding Rehabilitation Hospital
Shared therapeutic areas:
Herbert B Slade, MD
Healthpoint
Shared therapeutic areas:
Mark George, MD
Medical University of South Carolina
Shared therapeutic areas:
Hagop Youssoufian, MD
Verastem, Inc.
Shared therapeutic areas:
Murad Alam, MD
Northwestern University
Shared therapeutic areas:
Suman Sheraz, PhD*
Riphah International University
Shared therapeutic areas:
Jack A Yanovski, M.D.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Shared therapeutic areas:
Publications (0)
No publications found for this investigator.
Clinical Trials (30)
Showing 20 of 30 trials
A Bioequivalence Study Between Two Brands of Medications to Treat Cough & Cold Symptoms
A Comparison of Three Medications to Treat Diarrhea in Adults.
Smoking Reduction or Cessation With Nicotine Replacement Therapy
Efficacy and Safety Following Use of a Novel Nicotine Replacement Therapy
Photoirritation and Photoallergic Potential of a New Nicotine Patch
Skin Sensitization Potential of a New Nicotine Patch
Early Effects of a New Oral Nicotine Replacement Product and NiQuitin™ Lozenge
Single-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product
Multiple-dose Nicotine Pharmacokinetics With a New Oral Nicotine Replacement Product.
To Test Bioequivalence Between Two Formulations of Paracetamol/Phenylephrine
Bioequivalence Between Nicotine Replacement Products and Nicorette® Gum
Pharmacokinetics With Two New Oral Nicotine Replacement Products and Nicorette® Gum
Pharmacokinetics With a New Oral Nicotine Replacement Product and Nicorette® Gum
Bioequivalence Between an Oral Nicotine Replacement Product and Nicorette® Gum
Comparative Pharmacokinetic Study of New Oral Nicotine Replacement Therapy Products.
Single-dose Pharmacokinetics of Oral Nicotine Replacement Products
Single-dose Nicotine Pharmacokinetics With Three Oral Nicotine Replacement Products. A Study in Healthy Smokers.
Single-dose Nicotine Pharmacokinetics With Four Oral Nicotine Replacement Products
Bioequivalence Between Two Oral Nicotine Sublingual Tablets, 2 mg and 4 mg
Bioequivalence Between Two New Oral Nicotine Replacement Therapy Products and Nicorette® Microtab